We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$18.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow %
98.77%
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$355M
2
AAPL icon
Apple
AAPL
+$344M
3
CVX icon
Chevron
CVX
+$323M
4
JPM icon
JPMorgan Chase
JPM
+$296M
5
XOM icon
ExxonMobil
XOM
+$285M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Financials 12.69%
3 Technology 11.8%
4 Energy 9.95%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENZL icon
1051
iShares MSCI New Zealand ETF
ENZL
$77.6M
$262K ﹤0.01%
+7,800
New +$288K
AAV
1052
DELISTED
Advantage Oil & Gas Ltd
AAV
$262K ﹤0.01%
+66,600
New +$264K
WLFC icon
1053
Willis Lease Finance
WLFC
$1.65B
$259K ﹤0.01%
+57,405
New +$259K
CST
1054
DELISTED
CST Brands, Inc.
CST
$259K ﹤0.01%
+8,422
New +$268K
LAZ icon
1055
Lazard
LAZ
$4B
$257K ﹤0.01%
+8,000
New +$267K
WMK icon
1056
Weis Markets
WMK
$1.92B
$257K ﹤0.01%
+5,700
New +$239K
AROC icon
1057
Archrock
AROC
$6.16B
$253K ﹤0.01%
+9,000
New +$247K
HUN icon
1058
Huntsman Corp
HUN
$2.1B
$251K ﹤0.01%
+15,132
New +$277K
VNO icon
1059
Vornado Realty Trust
VNO
$7.65B
$250K ﹤0.01%
+4,133
New +$255K
CMLS
1060
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$247K ﹤0.01%
+9,113
New +$251K
AVNT icon
1061
Avient
AVNT
$3.29B
$244K ﹤0.01%
+9,837
New +$239K
RING icon
1062
iShares MSCI Global Gold Miners ETF
RING
$2.26B
$241K ﹤0.01%
+12,025
New +$295K
CSGP icon
1063
CoStar Group
CSGP
$12.2B
$240K ﹤0.01%
+18,580
New +$210K
XRTX
1064
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
$238K ﹤0.01%
+23,670
New +$252K
BIO icon
1065
Bio-Rad Laboratories Class A
BIO
$8.76B
$236K ﹤0.01%
+2,100
New +$246K
CHK
1066
DELISTED
Chesapeake Energy Corporation
CHK
$235K ﹤0.01%
+61
New +$234K
NRIM icon
1067
Northrim BanCorp
NRIM
$593M
$232K ﹤0.01%
+38,344
New +$212K
BTH
1068
DELISTED
BLYTH,INC
BTH
$232K ﹤0.01%
+16,600
New +$255K
AFG icon
1069
American Financial Group
AFG
$11.9B
$230K ﹤0.01%
+4,700
New +$227K
NATR icon
1070
Nature's Sunshine
NATR
$362M
$229K ﹤0.01%
+14,000
New +$216K
NSR
1071
DELISTED
Neustar Inc
NSR
$229K ﹤0.01%
+4,700
New +$217K
UGI icon
1072
UGI
UGI
$7.87B
$219K ﹤0.01%
+8,400
New +$221K
NLY icon
1073
Annaly Capital Management
NLY
$17.3B
$209K ﹤0.01%
+4,148
New +$242K
OLP
1074
One Liberty Properties
OLP
$542M
$204K ﹤0.01%
+9,300
New +$219K
PGNX
1075
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$203K ﹤0.01%
+45,436
New +$204K
41 42
43
44 45

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Pfizer: 12,852,527 shares worth $342M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.

  • Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
  • Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
  • Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.

Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.